Last reviewed · How we verify
Commercial tablet with water
At a glance
| Generic name | Commercial tablet with water |
|---|---|
| Sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants (PHASE1)
- Relative Bioavailability Study of Nirmatrelvir/Ritonavir Oral Powder Relative to the Commercial Tablets and Estimation of the Effect of Food on Bioavailability of the Nirmatrelvir/Ritonavir Oral Powder in Healthy Participants. (PHASE1)
- Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet (PHASE1)
- Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil (PHASE1)
- Bioequivalence Of Zoloft ODT To Jzoloft In Healthy Japanese Subjects (PHASE1)
- Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water (PHASE1)
- Evaluation of Meclizine Orodispersible Tablet Pharmacokinetic in Human Volunteers (PHASE1, PHASE2)
- A Study of Baricitinib in Healthy Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: